Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Broadcom
AVGO
|
$1.58B |
| 2 |
Meta Platforms (Facebook)
META
|
$401M |
| 3 |
NVIDIA
NVDA
|
$333M |
| 4 |
Cintas
CTAS
|
$246M |
| 5 |
Costco
COST
|
$236M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$284M |
| 2 |
JPMorgan Chase
JPM
|
$178M |
| 3 |
WIRE
Encore Wire Corp
WIRE
|
$160M |
| 4 |
Intel
INTC
|
$152M |
| 5 |
D.R. Horton
DHI
|
$148M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Rallybio
RLYB
$22.4M
| $24.8K | ﹤0.01% | 21,203 | – | – |
|
3327
Cocrystal Pharma
COCP
$15.4M
| $24.8K | ﹤0.01% | +14,092 | New | +$24.8K |
|
3328
CPS Technologies
CPSH
$50.1M
| $23.6K | ﹤0.01% | 16,637 -299 | -2% | -$425 |
|
3329
Lyell Immunopharma
LYEL
$213M
| $22.9K | ﹤0.01% | 16,601 -23,497 | -59% | -$32.4K |
|
|
OKUR
3330
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $22.7K | ﹤0.01% | 13,327 | – | – |
|
|
JBIO
3331
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $22.1K | ﹤0.01% | 10,579 -1,049 | -9% | -$2.19K |
|
3332
Great Elm Group
GEG
$70.6M
| $21.8K | ﹤0.01% | 11,419 | – | – |
|
|
SLI
3333
Standard Lithium
SLI
$600M
| $20.8K | ﹤0.01% | 12,929 | – | – |
|
3334
Compass Therapeutics
CMPX
$483M
| $20.5K | ﹤0.01% | 11,117 | – | – |
|
|
AHT
3335
Ashford Hospitality Trust
AHT
$36.7M
| $20.1K | ﹤0.01% | 26,910 -329,139 | -92% | -$246K |
|
|
SY
3336
So-Young International
SY
$381M
| $18.4K | ﹤0.01% | 19,737 -50,838 | -72% | -$47.3K |
|
3337
Invivyd
IVVD
$204M
| $17.9K | ﹤0.01% | 17,327 -47,198 | -73% | -$48.7K |
|
3338
NanoViricides
NNVC
$22.3M
| $17.9K | ﹤0.01% | +11,915 | New | +$17.9K |
|
3339
Zevia
ZVIA
$210M
| $17.5K | ﹤0.01% | 16,239 | – | – |
|
3340
CEL-SCI Corp
CVM
$71.8M
| $17.5K | ﹤0.01% | 16,484 | – | – |
|
3341
Vor Biopharma
VOR
$250M
| $17K | ﹤0.01% | 24,219 | – | – |
|
3342
Spero Therapeutics
SPRO
$116M
| $13.4K | ﹤0.01% | 10,003 | – | – |
|
3343
Co-Diagnostics
CODX
$12.7M
| $13.2K | ﹤0.01% | 10,542 | – | – |
|
3344
PEDEVCO
PED
$55.9M
| $11.9K | ﹤0.01% | 12,700 | – | – |
|
3345
Village Farms International
VFF
$368M
| $11.5K | ﹤0.01% | 12,380 | – | – |
|
3346
Cue Biopharma
CUE
$60M
| $10.9K | ﹤0.01% | 14,575 -199,514 | -93% | -$149K |
|
3347
Energy Vault
NRGV
$327M
| $10.7K | ﹤0.01% | 11,109 | – | – |
|
|
TMQ
3348
Trilogy Metals
TMQ
$278M
| $10.5K | ﹤0.01% | 21,693 | – | – |
|
3349
SES AI
SES
$399M
| $9.1K | ﹤0.01% | 14,219 | – | – |
|
3350
PotlatchDeltic
PCH
$3.25B
| – | – | -37,550 | Closed | -$1.48M |
|